Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2

Molecular Cell

Volumn 61, Issue 4, 2016, Pages 520-534

  Redis, Roxana S ^a   Vela, Luz E ^b   Lu, Weiqin ^a   Ferreira de Oliveira, Juliana ^c   Ivan, Cristina ^a   Rodriguez Aguayo, Cristian ^a   Adamoski, Douglas ^c   Pasculli, Barbara ^a   Taguchi, Ayumu ^a   Chen, Yunyun ^a   Fernandez, Agustin F ^d   Valledor, Luis ^e   Van Roosbroeck, Katrien ^a   Chang, Samuel ^a   Shah, Maitri ^a   Kinnebrew, Garrett ^f   Han, Leng ^g   Atlasi, Yaser ^h,n   Cheung, Lawrence H ^a   Huang, Gilbert Y ^a   Monroig, Paloma ^a   Ramirez, Marc S ^a   Catela Ivkovic, Tina ^a,i   Van, Long ^b   Ling, Hui ^a   Gafà, Roberta ^j   Kapitanovic, Sanja ⁱ   Lanza, Giovanni ^j   Bankson, James A ^a   Huang, Peng ^a   Lai, Stephen Y ^a   Bast, Robert C ^a   Rosenblum, Michael G ^a   Radovich, Milan ^f   Ivan, Mircea ^f   Bartholomeusz, Geoffrey ^a   Liang, Han ^a   Fraga, Mario F ^k   Widger, William R ^b   Hanash, Samir ^a   Berindan Neagoe, Ioana ^a,l,m   Lopez Berestein, Gabriel ^a   Ambrosio, Andre L B ^c   Gomes Dias, Sandra M ^c   Calin, George A ^a   more..

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b University of Houston   (United States)

^c BRAZILIAN CENTER FOR RESEARCH IN ENERGY AND MATERIALS CNPEM   (Brazil)

^d DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^e UNIVERSITY OF OVIEDO   (Spain)

^f INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF TEXAS   (United States)

^h JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

ⁱ RUDER BO KOVI INSTITUTE   (Croatia)

^j UNIVERSITY OF FERRARA   (Italy)

^k CINN CSIC UNIOVI PA   (Spain)

^l IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^m THE ONCOLOGY INSTITUTE PROF DR ION CHIRICUTA   (Romania)

ⁿ RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMINASE; LONG UNTRANSLATED RNA; MESSENGER RNA PRECURSOR; CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR; CLEAVAGE FACTOR IM, HUMAN; LONG NON-CODING RNA CCAT2, HUMAN; MESSENGER RNA; RNA PRECURSOR;

ALLELE; ALTERNATIVE RNA SPLICING; AMPLICON; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER METABOLISM; CANCER RISK; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; ENERGY METABOLISM; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INTRON; MALE; MALIGNANT NEOPLASTIC DISEASE; METABOLISM; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SINGLE NUCLEOTIDE POLYMORPHISM; CHEMISTRY; GENETICS; HCT116 CELL LINE; NEOPLASM;

ALLELES; ALTERNATIVE SPLICING; ENERGY METABOLISM; GLUTAMINASE; HCT116 CELLS; HUMANS; MRNA CLEAVAGE AND POLYADENYLATION FACTORS; NEOPLASMS; RNA PRECURSORS; RNA, LONG NONCODING; RNA, MESSENGER;

EID: 84958109207     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2016.01.015     Document Type: Article

References (42)

1. Bester A.C., Roniger M., Oren Y.S., Im M.M., Sarni D., Chaoat M., Bensimon A., Zamir G., Shewach D.S., Kerem B. Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell 2011, 145:435-446.
2. Boroughs L.K., DeBerardinis R.J. Metabolic pathways promoting cancer cell survival and growth. Nat. Cell Biol. 2015, 17:351-359.
3. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012, 487:330-337. Cancer Genome Atlas Network.
4. Carroll P.A., Diolaiti D., McFerrin L., Gu H., Djukovic D., Du J., Cheng P.F., Anderson S., Ulrich M., Hurley J.B., et al. Deregulated Myc requires MondoA/Mlx for metabolic reprogramming and tumorigenesis. Cancer Cell 2015, 27:271-285.
5. Cassago A., Ferreira A.P., Ferreira I.M., Fornezari C., Gomes E.R., Greene K.S., Pereira H.M., Garratt R.C., Dias S.M., Ambrosio A.L. Mitochondrial localization and structure-based phosphate activation mechanism of Glutaminase C with implications for cancer metabolism. Proc. Natl. Acad. Sci. USA 2012, 109:1092-1097.
6. Chen J.Q., Russo J. Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells. Biochim. Biophys. Acta 2012, 1826:370-384.
7. Elkon R., Ugalde A.P., Agami R. Alternative cleavage and polyadenylation: extent, regulation and function. Nat. Rev. Genet. 2013, 14:496-506.
8. Gao P., Tchernyshyov I., Chang T.C., Lee Y.S., Kita K., Ochi T., Zeller K.I., De Marzo A.M., Van Eyk J.E., Mendell J.T., Dang C.V. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 2009, 458:762-765.
9. Huang F., Zhang Q., Ma H., Lv Q., Zhang T. Expression of glutaminase is upregulated in colorectal cancer and of clinical significance. Int. J. Clin. Exp. Pathol. 2014, 7:1093-1100.
10. Jacque N., Ronchetti A.M., Larrue C., Meunier G., Birsen R., Willems L., Saland E., Decroocq J., Thiago T.T., Lambert M., et al. Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-inhibition. Blood 2015, 126:1346-1356.
11. Jeong S.M., Xiao C., Finley L.W., Lahusen T., Souza A.L., Pierce K., Li Y.H., Wang X., Laurent G., German N.J., et al. SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism. Cancer Cell 2013, 23:450-463.
12. Kaldma A., Klepinin A., Chekulayev V., Mado K., Shevchuk I., Timohhina N., Tepp K., Kandashvili M., Varikmaa M., Koit A., et al. An in situ study of bioenergetic properties of human colorectal cancer: the regulation of mitochondrial respiration and distribution of flux control among the components of ATP synthasome. Int. J. Biochem. Cell Biol. 2014, 55:171-186.
13. Katt W.P., Ramachandran S., Erickson J.W., Cerione R.A. Dibenzophenanthridines as inhibitors of glutaminase C and cancer cell proliferation. Mol. Cancer Ther. 2012, 11:1269-1278.
14. Le A., Lane A.N., Hamaker M., Bose S., Gouw A., Barbi J., Tsukamoto T., Rojas C.J., Slusher B.S., Zhang H., et al. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab. 2012, 15:110-121.
15. Ling H., Fabbri M., Calin G.A. MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat. Rev. Drug Discov. 2013, 12:847-865.
16. Ling H., Spizzo R., Atlasi Y., Nicoloso M., Shimizu M., Redis R.S., Nishida N., Gafà R., Song J., Guo Z., et al. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res. 2013, 23:1446-1461.
17. Lutz C.S., Moreira A. Alternative mRNA polyadenylation in eukaryotes: an effective regulator of gene expression. Wiley Interdiscip. Rev. RNA 2011, 2:23-31.
18. Lyubchenko Y.L., Shlyakhtenko L.S., Ando T. Imaging of nucleic acids with atomic force microscopy. Methods 2011, 54:274-283.
19. Masamha C.P., Xia Z., Yang J., Albrecht T.R., Li M., Shyu A.B., Li W., Wagner E.J. CFIm25 links alternative polyadenylation to glioblastoma tumour suppression. Nature 2014, 510:412-416.
20. Mercer T.R., Dinger M.E., Mattick J.S. Long non-coding RNAs: insights into functions. Nat. Rev. Genet. 2009, 10:155-159.
21. Millevoi S., Loulergue C., Dettwiler S., Karaa S.Z., Keller W., Antoniou M., Vagner S. An interaction between U2AF 65 and CF I(m) links the splicing and 3' end processing machineries. EMBO J. 2006, 25:4854-4864.
22. Naganuma T., Nakagawa S., Tanigawa A., Sasaki Y.F., Goshima N., Hirose T. Alternative 3'-end processing of long noncoding RNA initiates construction of nuclear paraspeckles. EMBO J. 2012, 31:4020-4034.
23. Nagasaki H., Arita M., Nishizawa T., Suwa M., Gotoh O. Automated classification of alternative splicing and transcriptional initiation and construction of visual database of classified patterns. Bioinformatics 2006, 22:1211-1216.
24. Orengo J.P., Bundman D., Cooper T.A. A bichromatic fluorescent reporter for cell-based screens of alternative splicing. Nucleic Acids Res. 2006, 34:e148.
25. Rathore M.G., Saumet A., Rossi J.F., de Bettignies C., Tempé D., Lecellier C.H., Villalba M. The NF-κB member p65 controls glutamine metabolism through miR-23a. Int. J. Biochem. Cell Biol. 2012, 44:1448-1456.
26. Redis R.S., Sieuwerts A.M., Look M.P., Tudoran O., Ivan C., Spizzo R., Zhang X., de Weerd V., Shimizu M., Ling H., et al. CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations. Oncotarget 2013, 4:1748-1762.
27. Stine Z.E., Walton Z.E., Altman B.J., Hsieh A.L., Dang C.V. MYC, Metabolism, and Cancer. Cancer Discov. 2015, 5:1024-1039.
28. Tian B., Pan Z., Lee J.Y. Widespread mRNA polyadenylation events in introns indicate dynamic interplay between polyadenylation and splicing. Genome Res. 2007, 17:156-165.
29. Tomlinson I., Webb E., Carvajal-Carmona L., Broderick P., Kemp Z., Spain S., Penegar S., Chandler I., Gorman M., Wood W., et al. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat. Genet. 2007, 39:984-988. CORGI Consortium.
30. Tuupanen S., Turunen M., Lehtonen R., Hallikas O., Vanharanta S., Kivioja T., Björklund M., Wei G., Yan J., Niittymäki I., et al. The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. Nat. Genet. 2009, 41:885-890.
31. van den Heuvel A.P., Jing J., Wooster R.F., Bachman K.E. Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth. Cancer Biol. Ther. 2012, 13:1185-1194.
32. Vander Heiden M.G. Targeting cancer metabolism: a therapeutic window opens. Nat. Rev. Drug Discov. 2011, 10:671-684.
33. Wang J., Liu X., Wu H., Ni P., Gu Z., Qiao Y., Chen N., Sun F., Fan Q. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res. 2010, 38:5366-5383.
34. Wang J.B., Erickson J.W., Fuji R., Ramachandran S., Gao P., Dinavahi R., Wilson K.F., Ambrosio A.L., Dias S.M., Dang C.V., Cerione R.A. Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell 2010, 18:207-219.
35. Warburg O., Posener K., Negelein E. Über den Stoffwechsel der Carcinomzelle. Biochem. Zeitschr 1924, 152:309-344.
36. Ward P.S., Thompson C.B. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell 2012, 21:297-308.
37. Wilusz J.E., Sunwoo H., Spector D.L. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev. 2009, 23:1494-1504.
38. Xia Z., Donehower L.A., Cooper T.A., Neilson J.R., Wheeler D.A., Wagner E.J., Li W. Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3'-UTR landscape across seven tumour types. Nat. Commun. 2014, 5:5274.
39. Yang Q., Gilmartin G.M., Doublié S. The structure of human cleavage factor I(m) hints at functions beyond UGUA-specific RNA binding: a role in alternative polyadenylation and a potential link to 5' capping and splicing. RNA Biol. 2011, 8:748-753.
40. Yang F., Zhang H., Mei Y., Wu M. Reciprocal regulation of HIF-1α and lincRNA-p21 modulates the Warburg effect. Mol. Cell 2014, 53:88-100.
41. Yoon J.H., Srikantan S., Gorospe M. MS2-TRAP (MS2-tagged RNA affinity purification): tagging RNA to identify associated miRNAs. Methods 2012, 58:81-87.
42. Zhou Z., Licklider L.J., Gygi S.P., Reed R. Comprehensive proteomic analysis of the human spliceosome. Nature 2002, 419:182-185.